Skin cancer is the most common form of cancer in the U.S., with one in five Americans expected to be affected in their ...

Technology is already assisting with diagnoses, but experts predict better tools will become available in the not-too-distant ...

Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer at the point of care. The eponymous ...

Health care providers could soon use small devices powered by artificial intelligence to hover over moles or lesions and immediately check for common skin cancers, potentially reducing the need for ...

DermaSensor, an FDA-approved device for AI melanoma detection, was not studied in skin of color prior to approval, with data leading to its approval including only white patients. The FDA has ...

Discover a study where 3D total-body photography reduced the number of melanoma excisions compared to controls.

Scientists are developing a less invasive portable device that would use blood samples to detect colorectal cancers. No one looks forward to a colonoscopy. The procedure, which is used to screen ...

A new randomized clinical trial investigates whether 3D total-body photography improves melanoma detection and impacts biopsy rates in high-risk patients.

If detected early, the prognosis for skin cancer is excellent. An innovative full-body scanner linked to an AI diagnostic platform is set to help with early detection of melanoma. In just six ...

The Map My Mole app provides patients with a small lens attachment for their phones to capture high-quality images of concerning skin spots. These images are then uploaded for assessment by ...

About Verisante Technology, Inc. Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer. The Verisante Aura(TM) for skin cancer ...

Our research could one day make simpler early detection possible." The device detects a colon cancer secreted protein known as CCSP-2. The protein's presence in colon cancer cells is 78 times ...